| Elexacaftor co-potentiates the activity of F508del and gating mutants of CFTR G Veit, C Vaccarin, GL Lukacs Journal of Cystic Fibrosis 20 (5), 895-898, 2021 | 63 | 2021 |
| Copper Coordination Chemistry of Sulfur Pendant Cyclen Derivatives: An Attempt to Hinder the Reductive-Induced Demetalation in 64/67Cu Radiopharmaceuticals M Tosato, M Dalla Tiezza, NV May, AA Isse, S Nardella, L Orian, ... Inorganic Chemistry 60 (15), 11530-11547, 2021 | 33 | 2021 |
| Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators O Laselva, G Marzaro, C Vaccarin, I Lampronti, A Tamanini, G Lippi, ... Frontiers in Pharmacology 9, 719, 2018 | 26 | 2018 |
| Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment S Salmaso, F Mastrotto, M Roverso, V Gandin, S De Martin, D Gabbia, ... Journal of Controlled Release 340, 318-330, 2021 | 11 | 2021 |
| Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB) G Marzaro, I Lampronti, E D'Aversa, G Sacchetti, G Miolo, C Vaccarin, ... European Journal of Medicinal Chemistry 151, 285-293, 2018 | 11 | 2018 |
| Investigations using albumin binders to modify the tissue distribution profile of radiopharmaceuticals exemplified with folate radioconjugates SD Busslinger, AE Becker, C Vaccarin, LM Deberle, ML Renz, V Groehn, ... Cancers 15 (17), 4259, 2023 | 4 | 2023 |
| A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides D Beyer, C Vaccarin, X Deupi, AK Mapanao, S Cohrs, F Sozzi-Guo, ... EJNMMI research 13 (1), 32, 2023 | 3 | 2023 |
| New TMA (4, 6, 4′-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease C Tupini, A Chilin, A Rossi, I De Fino, A Bragonzi, E D’Aversa, ... International Journal of Molecular Sciences 23 (22), 14483, 2022 | 2 | 2022 |
| Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening C Vaccarin, D Gabbia, E Franceschinis, S De Martin, M Roverso, ... International Journal of Molecular Sciences 23 (19), 11528, 2022 | 2 | 2022 |
| Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4, 6, 4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis E Franceschinis, M Roverso, D Gabbia, S De Martin, M Brusegan, ... Pharmaceutics 14 (9), 1806, 2022 | 2 | 2022 |
| Preliminary discovery of small molecule inhibitors of epidermal growth factor receptor (EGFR) that bind to the extracellular domain R Di Liddo, M Verona, C Vaccarin, L Acquasaliente, S Schrenk, ... Cancers 14 (15), 3647, 2022 | 2 | 2022 |
| Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder C Vaccarin, AK Mapanao, LM Deberle, AE Becker, F Borgna, G Marzaro, ... Cancers 16 (7), 1262, 2024 | | 2024 |
| Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2 J Wang, D Beyer, C Vaccarin, Y He, M Tanriver, RM Benoit, X Deupi, L Mu, ... bioRxiv, 2024.03. 20.585792, 2024 | | 2024 |
| 625: Optimized modulator combinations for rare CFTR mutants with good responsiveness to single correctors G Veit, A Roldan, C Vaccarin, N Vadeboncoeur, L Bilodeau, E Matouk, ... Journal of Cystic Fibrosis 20, S297, 2021 | | 2021 |
| Sintesi di analoghi di TMA per la modulazione di CFTR C Vaccarin | | |
